Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy
Phase 1
Terminated
- Conditions
- Fallopian Tube CancerHigh Grade Serious or Endometrioid Carcinoma of the Ovary, Fallopian Tube, or Primary Peritoneal CancerPrimary Peritoneal CarcinomaOvarian Cancer
- Interventions
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- THERAPIM PTY LTD
- Target Recruit Count
- 16
- Registration Number
- NCT04814875
- Locations
- 🇦🇺
Blacktown Hospital, Blacktown, New South Wales, Australia
🇦🇺Mater Misericordiae Limited, South Brisbane, Queensland, Australia
🇦🇺Peninsula and Southeast Oncology, Frankston, Victoria, Australia
News
No news found